Skip to main content
. 2022 Nov 1;38(1):176–191. doi: 10.1080/14756366.2022.2135512

Figure 2.

Figure 2.

Some reported pyrazolopyridine derivatives and their IC50 values as anticancer and kinase inhibitors.